Treating patients with fibromyalgia in primary care settings under routine medical practice: a claim database cost and burden of illness study
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Introduction: The objective of this study was to analyze health care and non-health care resource utilization under routine medical practice in a primary care setting claims database and to estimate the incremental average cost per patient per year of fibromyalgia syndrome (FMS) compared with a reference population. Methods: A 12-month cross-sectional and retrospective study was completed using computerized medical records from a health provider database. Analyses were conducted from the perspective of the provider and from the viewpoint of society. Health care and non-health care resource utilization included drugs, complementary tests, all types of medical visits, referrals, hospitalizations, sick leave, and early retirement because of disability due to FMS. Patients with a diagnosis of FMS in accordance with ICD-10 (International Statistical Classification of Diseases and Related Health Problems, 10th revision) criteria were included in the analysis if they had at least one claim for FMS during the 12 months prior to the end of May 2007. A non-FMS comparison group was also created with the remaining subjects. Results: Of the 63,526 patients recruited for the study, 1,081 (1.7%) (96.7% of whom were women, 54.2 [10.1] years old) met the criteria for FMS. After an adjustment for age and gender, FMS subjects used significantly more health care resources than the reference population and had more sick leave and the percentage of subjects with premature retirement was also significantly higher (P < 0.001 in all cases). As a result, FMS subjects showed an incremental adjusted per-patient per-year total cost of €5,010 (95% confidence interval [CI] 3,494 to 6,076, +153%, P < 0.001) on average compared with non-FMS subjects. Significantly higher differences were observed in both health care and non-health care adjusted costs: €614 (404 to 823, +66%) and €4,394 (3,373 to 5,420, +189%), respectively (P < 0.001 in both cases). Annual drug expenditure per patient on average was considerably higher in FMS patients, €230 (124 to 335, +64%, P < 0.001), than the reference group. Conclusions: Under routine medical practice, patients with FMS were associated with considerably higher annual total costs in the primary care setting compared with the reference population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The american college of rheumatology 1990 criteria for the classification of fibromyalgia
Wolfe, F., Smythe, H. A., Yunus, M. B., Bennett, R. M., Bombardier, C., Goldenberg, D. L., Tugwell, P., Campbell, S. M., Abeles, M., Clark, P., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330203 · Cited by 9,563
How should cost data in pragmatic randomised trials be analysed?
Thompson, S. G. (2000) · BMJ · doi:10.1136/bmj.320.7243.1197 · Cited by 772 · cited 1×
“Costs between reference group and FMS patients were compared, in accordance with the recommendations of Thompson and Barber [31], using an ANCOVA with gender and age as covariates (with Bonferroni corrections for multiple-pair comparisons).”
MethodBoonen, A., van den Heuvel, R., van Tubergen, A., Goossens, M., Severens, J. L., van der Heijde, D., & van der Linden, S. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.019711 · Cited by 219 · cited 2×
“Total annual expenses for a patient with FMS entail more than twice the expenses incurred for a patient with ankylosing spondylitis and are similar to those of a patient with chronic lumbalgia [11-16].”
BackgroundValidación española del cuestionario Brief Pain Inventory en pacientes con dolor de causa neoplásica
Badia, X., Muriel, C., Gracia, A., Manuel Núñez-Olarte, J., Perulero, N., Gálvez, R., Carulla, J., & S. Cleeland, C. (2003) · Medicina Clínica · doi:10.1016/s0025-7753(03)73601-x · Cited by 217
Psychiatric comorbidities in a community sample of women with fibromyalgia
Raphael, K. G., Janal, M. N., Nayak, S., Schwartz, J. E., & Gallagher, R. M. (2006) · Pain · doi:10.1016/j.pain.2006.04.004 · Cited by 153
Medical and productivity costs of anxiety disorders: Case control study
Marciniak, M., Lage, M. J., Landbloom, R. P., Dunayevich, E., & Bowman, L. (2004) · Depression and Anxiety · doi:10.1002/da.10131 · Cited by 99
Cited by
A review of chronic pain impact on patients, their social environment and the health care system
Duenas, M., Ojeda, B., Salazar, A., Mico, J. A., & Failde, I. (2016) · Journal of Pain Research · doi:10.2147/jpr.s105892 · Cited by 985
“36,42,43 Recently, in a study carried out in Spain, it has been revealed that almost half of fibromyalgia patients had lost their capacity for work, 23% had obtained a disability pension for recognized incapacity for work status, and only 30% of them had work adaptations.”
BackgroundChronic diseases in the European Union: the prevalence and health cost implications of chronic pain
Leadley, R. M., Armstrong, N., Lee, Y. C., Allen, A., & Kleijnen, J. (2012) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.3109/15360288.2012.736933 · Cited by 282
“Depont et al. (2010), Sicras-Mainar et al. (2009), and Becker et al. (2010) were the only three out of the 10 studies that met all the requirements in the quality assessment list.2,17,19 In Muller-Schwefe et al. (2011), only source of data and patients’ type of pain were mentioned in the method…”
Background(2014) · Handbook of Clinical Neurology · doi:10.1016/b978-0-7020-4086-3.00033-3 · Cited by 86
Pain and Functional Capacity in Female Fibromyalgia Patients
Carbonell-Baeza, A., Aparicio, V. A., Sjöström, M., Ruiz, J. R., & Delgado-Fernández, M. (2011) · Pain Medicine · doi:10.1111/j.1526-4637.2011.01239.x · Cited by 60
Cabrera, V., Martín-Aragón, M., Terol, M. D. C., Núñez, R., & Pastor, M. D. L. Á. (2015) · Terapia psicológica · doi:10.4067/s0718-48082015000300003 · Cited by 51
Metadata
- Authors
- Sicras-Mainar, A., Rejas, J., Navarro, R., Blanca, M., Morcillo, Á., Larios, R., Velasco, S., & Villarroya, C.
- Venue
- Arthritis Research & Therapy
- Published
- 2009-04-14
- Volume
- 11
- Issue
- 2
- Pages
- R54-R54
- ISSN
- 1478-6354 (ISSN-L)
- OpenAlex
- W2008404851
- Cited by
- 137
- References
- 6
- FWCI
- 8.49
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treating patients with fibromyalgia in primary care settings under routine medical practice: a claim database cost and burden of illness study. https://app.cochat.ai/papers/10.1186/ar2673
- The paper
- Sicras-Mainar, A., Rejas, J., Navarro, R., Blanca, M., Morcillo, Á., Larios, R., Velasco, S., & Villarroya, C. (2009). Treating patients with fibromyalgia in primary care settings under routine medical practice: a claim database cost and burden of illness study. Arthritis Research & Therapy. https://doi.org/10.1186/ar2673
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.